Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis.
about
Clinical features and management of autoimmune hepatitisAuto immune hepatitisManagement of autoimmune hepatitis: Focus on pharmacologic treatments beyond corticosteroidsReview article: the management of autoimmune hepatitis beyond consensus guidelinesDiagnosis and Management of Autoimmune Hepatitis: Current Status and Future DirectionsNon-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.Difficult treatment decisions in autoimmune hepatitis.Treatment of autoimmune hepatitis: a review of current and evolving therapies.Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae.Systematic review: managing suboptimal treatment responses in autoimmune hepatitis with conventional and nonstandard drugs.Treatment of autoimmune liver disease: current and future therapeutic options.Current status of therapy in autoimmune liver diseaseAutoimmune Hepatitis: Clinical Review with Insights into the Purinergic Mechanism of DiseaseAutoimmune hepatitis: focusing on treatments other than steroids.Management of patients with difficult autoimmune hepatitis.Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.Pharmacological management of autoimmune hepatitis.Budesonide for the treatment of autoimmune hepatitis.Review article: overlap syndromes and autoimmune liver disease.Review article: The prevention and reversal of hepatic fibrosis in autoimmune hepatitis.Current and prospective pharmacotherapy for autoimmune hepatitis.Current concepts in the diagnosis and management of autoimmune hepatitis.Acute-on-chronic liver failure: terminology, mechanisms and management.Expert clinical management of autoimmune hepatitis in the real world.Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis.Everolimus treatment for patients with autoimmune hepatitis and poor response to standard therapy and drug alternatives in use.Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.Refractory Autoimmune Hepatitis: Beyond Standard Therapy.Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis.Autoimmune Hepatitis in the Asia-Pacific Area.
P2860
Q22305507-36757C5E-1093-4140-91B6-4E05FC46ECE2Q26746242-C5DB206E-FDB2-4F6E-82F0-0F663CEFE751Q26859099-07A05E7E-F694-45CE-8E30-A4DE9D0C9BDCQ26864272-0A1ED1D4-5184-4831-9536-107FA6AAC631Q28076505-4715A354-9626-464A-A4C6-3D0E3DF96978Q33447479-6D53BB51-5DD5-40C5-AD05-7A0536524902Q33688293-2111D4B4-D48E-4CB8-B991-889A3C4B80F2Q34149523-E803217A-0147-4EEB-8F5A-60AC9DCFF143Q34292354-7C820088-41EC-4CA8-9AC8-B0A7172148EEQ34299536-7BEA713D-2802-4CF3-8FBB-5D7AC1E00D9CQ34342199-46EC53F0-CC41-4B22-B6C2-6A28611C3F66Q34408950-21663DBC-AF15-453D-B3D0-3A2CEEB97E17Q35906055-B93DA15D-36D1-461E-981B-11AFFD2CCC10Q36231841-71220C15-7DE1-42A8-8218-E8E2334AD516Q36379083-3EF82D67-6EFA-4212-81AF-1832A11A2043Q36490242-FD9141ED-0928-4DDE-8B53-EB222B703B88Q37828507-040570EB-8A5C-48B7-80BB-23A8122E9512Q37924059-0D94663E-ED22-41AE-BCFC-AEDE6111C14CQ38027909-E0361ADE-7585-489F-94CD-36B98C8BA382Q38175465-EBF509A7-BCA4-4B1F-A171-2F6D00C0E2DDQ38222882-C81964E0-7693-442B-8BB0-CFACCB9F4455Q38609184-DE396089-0712-42D1-B45A-9DDF50CF8A8BQ38720387-7B828600-9F76-4C7D-A3BE-AC819F4CC842Q38779430-14060307-E431-4681-ABA6-90A1008558C9Q38930837-DA0FF554-2993-4300-BD6A-CBB125865415Q41344505-945E3368-925A-4360-B5C4-74C5ED9B453AQ42358509-8B3EA653-0EB9-4161-91A2-B89C6FAA0C55Q46408372-D1BA59FF-7336-4622-AA65-3361FE264260Q51596178-497CF2B8-4CE5-49F6-9BCE-8DEB1AD58707Q55040971-8FAD8BC3-0BE6-4250-98CA-08082C8CD2D9
P2860
Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Low-dose tacrolimus ameliorate ...... fractory autoimmune hepatitis.
@ast
Low-dose tacrolimus ameliorate ...... fractory autoimmune hepatitis.
@en
type
label
Low-dose tacrolimus ameliorate ...... fractory autoimmune hepatitis.
@ast
Low-dose tacrolimus ameliorate ...... fractory autoimmune hepatitis.
@en
prefLabel
Low-dose tacrolimus ameliorate ...... fractory autoimmune hepatitis.
@ast
Low-dose tacrolimus ameliorate ...... fractory autoimmune hepatitis.
@en
P2093
P2860
P356
P1476
Low-dose tacrolimus ameliorate ...... fractory autoimmune hepatitis.
@en
P2093
Ben Vainer
Bent Adel Hansen
Fin Stolze Larsen
Martin Eefsen
Peter Nissen Bjerring
P2860
P304
P356
10.3748/WJG.V13.I23.3232
P407
P577
2007-06-01T00:00:00Z